Please login to the form below

Not currently logged in


This page shows the latest ASCO news and features for those working in and with pharma, biotech and healthcare.

Bayer signs €250m pact with India’s Curadev for STING drugs

Bayer signs €250m pact with India’s Curadev for STING drugs

There’s still interest in STING agonists, despite disappointing results for Novartis/Aduro’s ADU-S100 at last year’s ASCO meeting – which resulted in Novartis handing back rights to the

Latest news

More from news
Approximately 21 fully matching, plus 132 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never ... He is an active member of the American Society of Clinical

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • RWE Blog 3: Is real-world evidence the holy grail

    Some publications are negative on the use of RWD. An American Society of Clinical Oncology (ASCO) March 2019 publication detailed how RWE could lead to false claims regarding effectiveness, and concluded

  • ASCO 2019 – the highlights

    Over 40, 000 oncology professionals from around the world attended this year’s American Society of Clinical Oncology (ASCO) annual meeting.

  • Artificial Intelligence in healthcare

    Poster presented at: 2017 American Society of Clinical Oncology (ASCO) Annual Meeting; June 3, 2017; Chicago, IL.

  • How did pharma use Twitter at #ASCO16?

    Each year, ASCO’s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this ... ASCO’s Annual Meeting has led the way in terms of social

  • ASCO 2015: What you missed in Chicago

    Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30, 000 delegates together to talk about innovations ... Three monoclonal antibodies were presented on the last day

More from PMHub
Approximately 2 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...